Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.47
Delayed Data
As of Apr 20
 +0.0099 / +0.68%
Today’s Change
1.28
Today|||52-Week Range
6.15
-15.52%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close1.46
Today’s open1.46
Day’s range1.44 - 1.49
Volume71,091
Average volume (3 months)269,325
Market cap$18.7M
Data as of 3:59pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+35.19%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-56.64%
P/E ratioNM
Price/Sales21.49
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...-0.01-2.81%
ACSTAcasti Pharma Inc-0.07-6.48%
HTBXHeat Biologics Inc-0.11-9.02%
KTOVKitov Pharma Ltd-0.04-1.54%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 15, 2018
EPS forecast (this quarter)--
Annual revenue (last year)$843.0K
Annual profit (last year)-$11.8M
Net profit margin-1,398.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts